Xuewu Liu’s Substack · Aug 18, 2026
The Closed Loop: Why Intratumoral ClO₂ May Be a Genuine Answer for Glioblastoma
0Sign in to vote or save
Since filing for FDA Orphan Drug Designation for glioblastoma on April 8, we have steadily added to the evidence base behind the intratumoral ClO₂ ablation system — more veterinary tumor cases, and a closer look at how fast and how completely the reaction self-limits, most recently in whole blood.
Comments
Nothing yet. Say the first thing.
Sign in to join the conversation.